[Diabetes Mellitus, Coronary Artery Disease and Heart Disease]

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2016 Apr 8

PMID 27052249

Citations 4

Authors

Martin Clodi

Christoph Saly

Friedrich Hoppichler

Michael Resl

Clemens Steinwender

Bernd Eber

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus, cardiovascular disease and heart failure are interacting dynamically. Patients being diagnosed with cardiovascular disease should be screened for diabetes mellitus. Enhanced cardiovascular risk stratification based on biomarkers, symptoms and classical risk factors should be performed in patients with pre-existing diabetes mellitus.

Citing Articles

Can the WHO 's recommendations of physical activity volume decrease the risk of heart disease in middle and older aged Chinese People: the evidence from a seven year longitudinal survey.

Ding M, Zhou Y, Li C, Li W, Jia N, Dong X BMC Geriatr. 2022; 22(1):596.

PMID: 35850665 PMC: 9290295. DOI: 10.1186/s12877-022-03276-0.

The Efficacy of Double-Heart Nursing in Combination with Seaweed Polysaccharide for Patients with Coronary Heart Disease Complicated with Diabetes: A Pilot, Randomized Clinical Trial.

Hu Y, Wang Y, An F, Dai N Dis Markers. 2022; 2022:2159660.

PMID: 35419116 PMC: 9001089. DOI: 10.1155/2022/2159660.

Antidiabetic Activity and Potential Mechanism of Amentoflavone in Diabetic Mice.

Su C, Yang C, Gong M, Ke Y, Yuan P, Wang X Molecules. 2019; 24(11).

PMID: 31212585 PMC: 6600559. DOI: 10.3390/molecules24112184.

Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators.

Cenik F, Schoberwalter D, Keilani M, Maehr B, Wolzt M, Marhold M Wien Klin Wochenschr. 2016; 128(21-22):802-808.

PMID: 27457876 PMC: 5104798. DOI: 10.1007/s00508-016-1045-2.

References

Cubbon R, Rajwani A, Abbas A, Gale C, Grant P, Wheatcroft S . Hyperglycaemia, in relation to sex, and mortality after acute coronary syndrome. Eur J Cardiovasc Prev Rehabil. 2007; 14(5):666-71. DOI: 10.1097/HJR.0b013e32827ab6c1. View

Scirica B, Bhatt D, Braunwald E, Steg P, Davidson J, Hirshberg B . Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013; 369(14):1317-26. DOI: 10.1056/NEJMoa1307684. View

Huelsmann M, Neuhold S, Strunk G, Moertl D, Berger R, Prager R . NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J. 2008; 29(18):2259-64. DOI: 10.1093/eurheartj/ehn334. View

Iribarren C, Karter A, Go A, Ferrara A, Liu J, Sidney S . Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001; 103(22):2668-73. DOI: 10.1161/01.cir.103.22.2668. View

Eurich D, Majumdar S, McAlister F, Tsuyuki R, Johnson J . Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care. 2005; 28(10):2345-51. DOI: 10.2337/diacare.28.10.2345. View

Evans J, Doney A, AlZadjali M, Ogston S, Petrie J, Morris A . Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus. Am J Cardiol. 2010; 106(7):1006-10. DOI: 10.1016/j.amjcard.2010.05.031. View

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P . Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2008; 360(2):129-39. DOI: 10.1056/NEJMoa0808431. View

Gerstein H, Miller M, Byington R, Goff Jr D, Thomas Bigger J, Buse J . Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24):2545-59. PMC: 4551392. DOI: 10.1056/NEJMoa0802743. View

White W, Cannon C, Heller S, Nissen S, Bergenstal R, Bakris G . Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013; 369(14):1327-35. DOI: 10.1056/NEJMoa1305889. View

10.

Green J, Bethel M, Armstrong P, Buse J, Engel S, Garg J . Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2015; 373(3):232-42. DOI: 10.1056/NEJMoa1501352. View

11.

Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N . Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364(9):829-841. PMC: 4109980. DOI: 10.1056/NEJMoa1008862. View

12.

Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24):2560-72. DOI: 10.1056/NEJMoa0802987. View

13.

Zinman B, Wanner C, Lachin J, Fitchett D, Bluhmki E, Hantel S . Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015; 373(22):2117-28. DOI: 10.1056/NEJMoa1504720. View

14.

Gerstein H, Bosch J, Dagenais G, Diaz R, Jung H, Maggioni A . Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012; 367(4):319-28. DOI: 10.1056/NEJMoa1203858. View

15.

Seferovic P, Paulus W . Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J. 2015; 36(27):1718-27, 1727a-1727c. DOI: 10.1093/eurheartj/ehv134. View

16.

Andersson C, Olesen J, Hansen P, Weeke P, Norgaard M, Jorgensen C . Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia. 2010; 53(12):2546-53. DOI: 10.1007/s00125-010-1906-6. View

17.

Dormandy J, Charbonnel B, Eckland D, Erdmann E, Massi-Benedetti M, Moules I . Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005; 366(9493):1279-89. DOI: 10.1016/S0140-6736(05)67528-9. View

18.

Booth G, Kapral M, Fung K, Tu J . Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006; 368(9529):29-36. DOI: 10.1016/S0140-6736(06)68967-8. View

19.

Zoungas S, Patel A, Chalmers J, de Galan B, Li Q, Billot L . Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010; 363(15):1410-8. DOI: 10.1056/NEJMoa1003795. View

20.

Saely C, Drexel H, Sourij H, Aczel S, Jahnel H, Zweiker R . Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study. Atherosclerosis. 2008; 199(2):317-22. DOI: 10.1016/j.atherosclerosis.2007.11.020. View